Project Details
| Status | Active |
|---|---|
| Effective start/end date | 02/28/24 → 09/30/26 |
Funding
- Allegheny-Singer Research Institute: $43,368.00
An Open-label Study Evaluating Pharmacokinetics, Efficacy, Safety, and Tolerability of CABENUVA IM Administered Monthly and Every 2 months in Virologically Suppressed HIV-Infected Adults having Severe Renal Impairment With or Without Hemodi
- Ma, Qing (PI)
- Shon, Alyssa (CoI)
Project: Research